LINDSAY TERRY: Open Payments
NPI 1205234465 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,098 in 43 payments from 14 companies in 2025. Trend: 2023 $951 · 2024 $1,435 · 2025 $1,098
Food & beverage: $1,026Education: $72
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 12 | $371 |
| Regeneron Healthcare Solutions, Inc. | 6 | $168 |
| Janssen Biotech, Inc. | 5 | $154 |
| LEO Pharma Inc. | 2 | $61 |
| Incyte Corporation | 3 | $57 |
| PFIZER INC. | 3 | $51 |
| ABBVIE INC. | 2 | $43 |
| Amgen Inc. | 2 | $37 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 2 | $33 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $33 |
Products named: DUPIXENT, LIBTAYO, TREMFYA, OPZELURA, CIBINQO, SKYRIZI, OTEZLA, ADBRY.
Industry payments across AZ — which companies pay providers there.
